While Insys Therapeutics, which profited wildly from the sale of a powerful fentanyl spray known as Subsys, was under investigation by federal prosecutors for its marketing practices in 2015. At that time the company's founder, John Kapoor told then-CEO Michael Babich that Babich would be the one who was going to shoulder the blame -- according to Babich, who has pleaded guilty to one count of mail fraud and one count of conspiracy. He is now a key witness in the racketeering prosecution of Kapoor and four other former executives and sales directors.

from Kaiser Health News http://bit.ly/2GuHXzy

0 comments:

Post a Comment

Popular Posts